Excellergy

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

Repair Biotechnologies is a biotechnology company developing therapies based on the cholesterol-degrading platform.

Skeletalis develops precision medicines targeting bone loss to treat osteoporosis and prevent fractures safely.

Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.

Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and prevent autoimmune diseases.

Curadel Surgical Innovations oversees the complete process of Curadel's FLARE contrast agents for image-guided surgery.

Ventuno Biotech is a biotech company that is developing innovative cancer therapies.

T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.

Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.

Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies

Treating the seeds of cancer

Nuclide Therapeutics provides radiopharmaceutical medicines that combine nuclear medicine and biotechnology.